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Abstract
Objectives Review available guidance for quality assurance
(QA) in mammography and discuss its contribution to har-
monise practices worldwide.
Methods Literature search was performed on different
sources to identify guidance documents for QA in mammog-
raphy available worldwide in international bodies, healthcare
providers, professional/scientific associations. The guidance
documents identified were reviewed and a selection was com-
pared for type of guidance (clinical/technical), technology and
proposed QA methodologies focusing on dose and image
quality (IQ) performance assessment.
Results Fourteen protocols (targeted at conventional and
digital mammography) were reviewed. All included recom-
mendations for testing acquisition, processing and display
systems associated with mammographic equipment. All
guidance reviewed highlighted the importance of dose as-
sessment and testing the Automatic Exposure Control (AEC)
system. Recommended tests for assessment of IQ showed
variations in the proposed methodologies. Recommended
testing focused on assessment of low-contrast detection,
spatial resolution and noise. QC of image display is recom-
mended following the American Association of Physicists in
Medicine guidelines.
Conclusions The existing QA guidance for mammography
is derived from key documents (American College of
Radiology and European Union guidelines) and proposes
similar tests despite the variations in detail and methodolo-
gies. Studies reported on QA data should provide detail on
experimental technique to allow robust data comparison.
Countries aiming to implement a mammography/QA pro-
gram may select/prioritise the tests depending on available
technology and resources.
Main messages
• An effective QA program should be practical to imple-
ment in a clinical setting.
• QA should address the various stages of the imaging
chain: acquisition, processing and display.
• AEC system QC testing is simple to implement and
provides information on equipment performance.
Keywords Mammography . Quality control . Quality
assurance . Dose . Image quality
Introduction
To ensure the key goals of mammography are achieved,
quality standards should be adopted. Ideally, these should
be wide in scope and address the various aspects with impact
on the mammography imaging process (e.g. technical, clin-
ical and training).
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A systematic approach for assessing critical performance
indicators can be achieved through the implementation of a
quality assurance (QA) program. QA provides a framework
for constant improvement through a feedback mechanism. It
allows the identification of deviations from optimum perfor-
mance of mammographic equipment, suboptimal clinical
practice and training needs [1–3].
An effective QA program should be practical to imple-
ment in a clinical setting. Adequate test equipment is neces-
sary as well as standard methodology that provides ability to
obtain the relevant objective, and subjective metrics of qual-
ity. Also, an effective QA program should be implementable
at a low or moderate cost [4].
The testing of equipment should address the various crit-
ical stages of the imaging chain (acquisition, processing and
display) and be implemented in a multidisciplinary team
approach by trained staff (radiographer, medical physicist,
radiologist) [3, 5].
In the past 20 years, several guidance documents have
been developed nationally and internationally to promote
quality in mammography. The scope of the guidance docu-
ments varies with some focused on technical aspects [4,
6–10], whereas others include also clinical aspects (e.g.
epidemiology, interventional, pathology, surgery) [7, 11].
The developments in digital mammography over the last
10 years have resulted in developments in QA programmes
and promoted the recommendation of new tests and proce-
dures for quality control [12].
This study aimed to identify, analyse and compare select-
ed protocols currently available for QA in mammography,
and to discuss their contribution to harmonise practices in
mammography worldwide.
This review aims to provide useful guidance to countries
aiming to implement (or further develop) a QA program in
mammography.
Methods
An extensive search was performed to identify guidance
documents and protocols for QA in mammography.
Sources used included scientific databases, organisations
of national healthcare systems (hospitals, regulatory bod-
ies, etc.), international agencies (e.g. International Atomic
Energy Agency [IAEA], International Commission on
Radiological Protection [ICRP]), professional colleges
(e.g. American College of Radiology [ACR], Royal
College of Radiologists [RCR]) and scientific associations
(e.g. Institution of Physics and Engineering in Medicine
[IPEM], American Association of Physicists in Medicine
[AAPM]). The search returned various documents pub-
lished in English, French, Portuguese, Spanish, German, Italian,
Swedish and Dutch. Only documents published in English or
French were considered for comparability issues, as other lan-
guages were not mastered by the team.
The guidance documents identified were reviewed and
compared for structure, editorial details, target staff profiles,
technologies addressed and type of guidance (technical and
clinical). Comparative tables are presented summarising the
most relevant findings.
Results
Guidance documents for QA and quality control (QC)
in mammography
Fourteen guidance documents for QA and QC in mammog-
raphy published between 1991 and 2011 were identified
(Table 1). Two are recommended by European bodies
(European Reference Organisation for Quality Assured
Breast Screening and Diagnostic Services [EUREF] and
European Commission [EC]), three are internationally
proposed by the IAEA and ten have national or regional
scope (United States of America [USA], Canada, Australia,
United Kingdom [UK], Ireland, Nordic) by governmental
bodies, professional and/or scientific organisations.
Guidance documents for QA and QC in mammography—
scope and professional groups targeted
Four documents address both conventional and digital mam-
mography. All documents are primarily focused on provid-
ing technical guidance. Three documents include both tech-
nical and clinical guidance.
Thirteen documents are targeted at medical physicists and
nine also include guidance for radiographers and radiolo-
gists. One protocol is specifically targeted at radiographers
(Table 2).
The EC protocol, Australian and Irish protocols are
broader in scope and include guidance to epidemiologists,
nurses, oncologists and surgeons.
Performance testing of mammographic systems and breast
dose assessment
Most documents (exceptions are the European Protocol [EP]
and IAEA-D protocols) recommend performance testing of
the three main stages of the mammography imaging chain
(Tables 3, 4, 5, 6 and 7):
1. Image acquisition (the stage with more intensive
testing)
2. Image processing (following the manufacturers’
recommendations)
3. Image display (includes monitor and printer testing)
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Testing the image acquisition system
X-ray production system All documents recommend testing
the generator and X-ray source, the Automatic Exposure
Control (AEC) and the breast compression systems.
Recommended tests include (1) alignment of X-ray field/light
field/image receptor area, (2) repeatability and accuracy of
tube output exposure, (3) half-value layer (HVL), (4) AEC
response versus breast thickness and tube voltage compensa-
tion and (5) alignment of the compression plate.
Breast dose Table 6 reviews the guidance for dosimetry
testing. All guidance documents provide recommendations
for assessment of breast dose and two (i.e. EP; IAEA-D) are
dedicated to this topic and include detailed methodology.
The mean glandular dose (MGD) is the recommended
parameter for assessing the risk of radiation-induced cancer
in mammography. Proposed methodologies for MGD as-
sessment (reviewed in Table 6) include:
& Measurements on patients using a thermoluminescent
dosimeter (TLD) (a minimum of ten patients is
recommended)
& Dose estimation from clinical exposure data (10–60 pa-
tients recommended)
& Dose estimation using test objects/phantoms (the en-
trance surface air kerma without backscatter (ESAK)
should be measured and multiplied by a conversion
factor, which compensates for X-ray beam quality, breast
thickness and composition (percentage glandularity)
The ESAK is required to calculate MGD and can be mea-
sured with a calibrated ionisation chamber (IC), semicon-
ductor dosimeter or TLDmaterial (Table 6). If measurements
include the effect of backscatter (e.g. TLDs), an appropriate
correction factor should be applied [6]. The recommended
phantoms to perform dosimetry testing vary between the
protocols (Table 6).
Also, the various protocols propose different methodolo-
gies to measure the required data for MGD calculation (e.g.
the ACR, Canadian and UK/IPEM propose measurements to
be performed at 40 mm from the chest wall edge, whereas the
EP recommends 60 mm).
Since the conversion factors used to estimate the MGD
from the incident air kerma depend on the X-ray beam
quality, it is necessary to keep track of the target/filter (T/F)
combination and tube voltage used in the experimental pro-
cedure, as well as the half-value layer (HVL) of the X-ray
beam.
The EC protocol proposes conversion factors by Dance
et al. (1990) and Dance et al. (2000), whereas the ACR uses
factors by Dance et al. (1990); Wu et al. (1991) and Sobol
et al. (1997) [9], the Canadian protocol uses Stanton et al.
(1984) and Wu et al. (1991) [13] and the Nordic protocol
propose conversion of Rosenstein et al. (1985) [14].
Image receptor The most frequently recommended tests for
digital mammography include (1) the system’s response
function, (2) image noise, (3) missed tissue at chest wall
edge, (4) signal homogeneity and (5) image artefacts
(Table 3).
Table 2 Guidance documents for QA and QC in mammography: target staff profiles, technologies and guidance type (clinical and/or technical)








Screen film Digital Technical Clinical Tolerances or
recommended
levels
IAEA-DM Y Y NA NA Y Y N Y
IAEA-SF Y Y NA Y NA Y Y Y
IAEA-D N Y N Y Y Y N Y
EC Y Y Y Y Y Y Y Y
EP NA Y N Y Y Y N Y
Nordic Protocol NA Y NA Y N Y NA Y
NHSBSP/UK NA Y NA NA Y Y N Y
RANZCR NA Y NA NA Y Y N Y
Irish Protocol Y Y Y Y Y Y Y Y
NQMCBSA Y Y Y Y Y Y N Y
ACR Y Y N Y N Y Y Y
IPEM/UK Y Y N Y Small Field Y N Y
Canadian Protocol N Y N Y Y Y N Y
Canadian Protocol N Y N Y Y Y N Y
Y yes, N no, NA not applicable/not available
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Some protocols propose specific tests for CR systems,
namely (1) inter-plate sensitivity variations, (2) image
artefacts, (3) evaluation of the influence of secondary
sources of radiation and (4) fading of the latent image
signal. Guidance is also included for testing the scanning
mechanism of the CR plate and the efficiency of the
erasure cycle. Specific tests for SFM are proposed in the
older protocols (EC protocol, UK/IPEM, Canada, IAEA-
SF) (Table 3).
Quality of the acquired image Table 7 summarises eight
groups of tests for assessment of IQ recommended in the
guidance documents reviewed. The tests address technical
and clinical IQ criteria using test objects and phantoms.
Phantoms and test objects The recommended phantoms to
produce the images for low contrast IQ assessment vary
between the protocols. CDMAM is frequently recommended
in Europe (EC PROTOCOL, UK/IPEM, UK/NHSBSP and
Ireland) whereas the ACR phantom is the standard in use in
the US and Canada.
IAEA does not recommend a particular phantom but
highlights the importance of using a phantom that contains
structures able to mimic those typically found in the breast.
For high-contrast IQ assessment the MTF is the key
recommended parameter. The MTF bar pattern method is
more straightforward to implement than the calculation of
the MTF using the edge phantom.
Image processing Image quality is affected by the process-
ing stage. For SF systems the guidance reviewed recom-
mends testing the performance of the chemical processor
(e.g. time, temperature, base and fog levels). The EC guide-
lines highlight the importance of testing image processing.
For digital mammography systems, the manufacturer’s guid-
ance should be followed because image-processing algo-
rithms are manufacturer-specific.
Artefacts Artefact analysis is an important test recommend-
ed in all guidelines reviewed. For SFM it focuses on artefacts
resulting from the chemical processing or from the degrada-
tion of the screen-film detector characteristics. In digital
systems, artefact analysis is focused on investigating prob-
lems originating in the image acquisition system and during
plate handling and processing (CR systems). Testing in-
cludes assessment originated by printing devices (e.g. laser
printers). A clinical evaluation protocol (type testing) is
available in the EUREF website (www.euref.org) and repeat-
ed/rejected analysis is recommended on the IAEA-DM
protocol.
Image display QA guidelines for testing image display sys-
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for testing electronic monitors and printers. The testing of
light boxes is included in the QC guidance for SFM systems
[11, 12, 16].
Test frequency and reference (or limiting) values
All guidance documents provide recommendations on
the frequency of the tests (Table 1). A number of tests
are recommended at acceptance only. Others should be
performed periodically (yearly, 6-monthly, monthly,
weekly or daily). Intermediate testing should be performed
when necessary (e.g. following major equipment repair).
The guidance documents also provide reference values
and pass/fail criteria. These originate from manufacturer
recommendations, expert knowledge, survey QC data,
baseline values and national policies (e.g. existing dose
reference levels). A critical aspect is to ascertain when
the measured (including uncertainties) is substantially
lower than the reference/limiting value. As an example,
UK/IPEM guidance recommends that measured values
for the relevant performance indicators not exceed one-
third of the range proposed for the limiting or remedial
values.
Discussion
The study showed that in the last 20 years comprehensive
guidance documents have been developed worldwide to
support the implementation of QA in mammography.
Target technology
The IAEA-DM protocol (edited 2011) is the most up-to-
date guidance and is dedicated to digital mammography.
The UK/IPEM, EC, IAEA-SF and ACR protocols are
well-established documents originally developed for
SFM that have been adopted in many countries world-
wide. The EC guidelines were updated and an addendum
on digital mammography was included [1, 17]. At the
date of submission of this paper, an updated version of
the ACR protocol is known to be in progress to include
guidance specifically targeted at digital mammography.
Also, as per information available on the EUREF website, a
revised edition (5th) of the EC Guidelines is in development
[18].
As new techniques in digital mammography are becom-
ing widespread, it is expected that revised versions of the
existing protocols will be produced, including guidance for
testing the capabilities of state of the art technology (e.g.
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Professional targets
The EC and Irish protocols are wider in scope and may be
useful to a broader range of healthcare professionals. Other
protocols focus on dosimetry and IQ assessment and are
targeted at medical physicists, radiographers and breast ra-
diologists. Hendrick et al. [5] showed that the profile of staff
performing QA testing differs between countries. Often,
radiographers are in charge of the most frequent tests (daily,
weekly), whereas medical physicists perform in-depth tech-
nical performance assessment (e.g. collimation, X-ray tube
output, and AEC testing). In Japan, radiographers perform
all QC testing, whereas in Finland, Iceland and Hungary the
service engineers tend to be in charge of the QC tasks. As
highlighted in the IAEA-DM protocol a critical aspect is that
QC testing is delegated to staff holding appropriate expertise
and training [4].
QA testing of mammographic systems and breast dose
assessment
Image detection and acquisition system
All protocols reviewed recommend testing the X-ray source
(tube voltage and HVL) and the AEC system. AEC testing is
one of the most important procedures due to its direct impact
on IQ and breast dose [19]. It should consider the effects of
variations in object/attenuator thickness and radiation beam
quality. Hendrick et al. [5] compared QC practices in 22
countries (affiliated with the International Breast Cancer
Screening Network) and concluded that this test that was
performed in all countries.
Breast dose The recommended methodologies for breast
dose estimation vary (Table 6). Measurements using test
objects and breast phantoms are frequently recommended
and more practical to implement than measurements based
on TLD techniques.
Dose assessment with a standard test object/phantom
facilitates the comparison of different mammographic tech-
niques and the investigation of the impact of technical set-
tings on breast dose [20, 21]. Clinical dose assessment (using
clinical exposure data) provide valuable information on the
clinical practice and takes into account the influence of
breast thickness and composition on dose [6].
Variations in dosimetry techniques in mammography may
prevent a robust comparison of breast dose in mammography
between countries and between radiology departments
[22–24].
Dance et al. [16] also highlighted that national protocols
adopt different phantoms, optical densities, measurement
points and conversion factors, which make it difficult to com-
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Hemdal et al. [23] measured the impact of variations in
experimental technique (e.g. positioning of the dosimeter,
compression plate in or out of the beam) on MGD values and
found noticeable variations.
When the European protocol was used, the value of the
MGD increased by 5±2 % (total variation 0–9 %) at clinical
settings and by 9±3 % (4–17 %) compared with the use of
the Nordic protocol [21]. The same authors also compared
measurements with different dosimeters (ionisation chambers
vs solid-state detectors) [23]. They concluded that HVL mea-
surements can be performed accurately with a sensitive solid-
state detector and a collimated radiation field, correcting for
energy dependence.
This review showed variations in the conversion factors
used in the estimation of breast dose (to account for X-ray
spectrum characteristics and breast composition) amongst
the guidance documents.
Zoetelief and Jansen [25] compared protocols for dosim-
etry in mammography and concluded that the use of different
radiation transport codes and different spectra could cause
differences in the conversion factor g by up to about 7 %. They
also showed that inclusion of the compression plate in the
beam results in a 4.5±1.5 % smaller g value for the same
HVL. Also, when breast thickness increases from 2 cm to
8 cm, the g value decreases by a factor of 4.
Tsai et al. [15] showed that the MGD calculated using
Dance’s method is 9–21 % higher than that using Wu’s
method. Jamal et al. [24] also compared MGD per film
considering eight different studies using different protocols
and conversion factors and found MGD values with notice-
able variations for a same breast thickness.
The MGD critically depends on the X-ray spectrum gen-
erated by the TF combination and tube voltage used. Modern
digital mammography systems offer innovative TF combi-
nations (e.g. W/Ag, W/Al) and new conversion factors have
been developed [24, 26, 27]. The protocols reviewed do not
yet include the most recent published data.
Quality of the acquired image All guidance reviewed rec-
ommends performing low-contrast threshold detection test-
ing, breast lesion visualisation (e.g. simulated in phan-
toms) and artefact analysis. Compression force, image
noise and spatial resolution testing are also recommend-
ed with variations in the proposed methods and test
materials.
The EC protocol recommends assessment of image qual-
ity of digital mammographic systems using images produced
with a specific low-contrast-detail test object (CDMAM)
[28, 29], which is a costly tool not readily available in all
imaging departments. The UK/IPEM and ACR protocols
recommend alternative test objects to CDMAM, namely
TOR (MAM) and the ACR accreditation phantom, respec-
tively. The choice of a suitable IQ phantom should take into
consideration the technology to be tested (screen-film of
digital). Huda et al. [30] examined the effectiveness of the
ACR phantom to assess image quality in digital mammog-
raphy and concluded that it is unsatisfactory due to an
inappropriate range and sensitivity to characterise simulated
breast lesions.
Variations in recommended test objects originate differ-
ences in reference/tolerance values (Table 7). The number
and type of recommended IQ tests varied (between 1 and 9)
as well as the recommended methodologies. Examples of
methods found in the guidance for rating IQ include absolute,
or relative, scales (e.g. five-step scale, 1 (worst) to 5 (best);
two-step scale with 1 (criterion was fulfilled) and 0 (criterion
was not fulfilled); four-step scale as designed by PGMI scale
(perfect, good, moderate and inadequate).
The guidance documents reviewed do not include recom-
mendations on observer training for IQ assessment. This
could be useful to reduce inter-observer variability in the
assessment of IQ.
Also, breast compression force is influenced by breast
thickness and composition. However, no recommendations
are provided to promote the optimisation of compression force
according to individual characteristics of the breast (compress-
ibility, composition and thickness) [31, 32]. Maximum values
for compression in mammography are recommended [7, 11,
33, 34].
The composition of breast tissue is an important issue
because increased breast density is known as a risk factor
for developing breast cancer [35]. Nevertheless, in the
reviewed QA guidance for IQ assessment breast density was
not used as a standard.
In 2011, an addendum to the EC protocol, containing
guidance for clinical evaluation of mammographic images,
was published promoting harmonisation in image quality
analysis. Clinical IQ assessment conducted by experienced
radiologists is important because it takes into account the
effects of image processing which may directly affect the
visibility of relevant features and the subsequent diagnostic
outcome [36].
Image display/presentation and processing
All protocols including guidance for digital mammography
recommend testing monitor displays and printers (Table 2).
No recommendations are provided regarding the format for
delivering mammography examinations/images to the pa-
tient and practices vary—some healthcare institutions deliv-
er the examination in hardcopy (paper or film), whereas
others provide digital images on CD.
Despite the potential critical impact of image processing
in the quality of the final image the testing of image process-
ing tools in still at early states (compared with testing of
hardware). Most protocols for testing digital mammography
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systems recommend testing based on raw image data and do
not include recommendations for testing post-processing
algorithms used in clinical images. Establishing testing pro-
tocols for post-processing tools in digital mammography is a
challenging task as processing tends to be manufacturer-
specific and frequently manufacturers are reluctant to reveal
details of the post-processing algorithms incorporated in
their systems. A recent publication [37] addresses briefly
the challenges of testing post-processing in tomosynthesis.
Work is in process in collaboration with the manufacturers of
digital breast tomosynthesis imaging systems to identify a
method for technical evaluation incorporating the clinically
used tomosynthesis reconstruction technique. Testing post-
processing tools in DM is a topic that requires further
research.
Conclusion
In this study the published guidance for QA in mammogra-
phy was reviewed. The recommended performance tests for
image acquisition, processing and display systems were
discussed and compared. Noticeable variations exist in the
proposed methods, test objects and phantoms. Also, refer-
ence values and acceptability criteria vary between proto-
cols, which raises the question of whether it would be pos-
sible to have a mammography system complying with a test
procedure and acceptability criteria, whereas using another
test procedure the system would fail.
Harmonisation and best practices in mammography
would benefit from more detailed guidance on the experi-
mental methods for QC testing and recommendations of
more affordable test equipment and materials that could be
acquired by the majority of X-ray departments.
When a recommended protocol cannot be implemented in
full, a selection of tests may be adequate. Selection criteria
should take into consideration resources and expertise avail-
able and the relevance of the tests to local practices. It should
be noted to highlight the value of testing the AEC system,
which is a simple procedure to implement that provides
valuable information on the overall performance of the mam-
mography system.
A key factor to promote the success of a QA program
for mammography is teamwork and the collaboration of
all key staff (e.g. radiographers, radiologists, medical
physicists and healthcare managers). Training and contin-
uous feedback mechanisms are essential to improve the
testing procedures and strengthen the outcomes of the
program.
Also, the use of professional networks and special interest
groups to exchange experiences with colleagues worldwide
can be of great value in the initial phases of implementation
of a mammography QA program.
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